In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function
about
Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect ProfilePharmacological investigations of N-substituent variation in morphine and oxymorphone: opioid receptor binding, signaling and antinociceptive activitySuperior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1]DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic painDevelopment and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box-Behnken design.Synthesis and biological evaluation of some novel 1-substituted fentanyl analogs in Swiss albino mice.Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships.In vivo pharmacological profile of substituted (3-pyridyl)-2-phenylisoxazolidine analogues of nicotine as novel antinociceptives.Variation of the net charge, lipophilicity, and side chain flexibility in Dmt(1)-DALDA: Effect on Opioid Activity and Biodistribution.Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists.and Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
P2860
Q27023246-D945DA50-42E6-44DE-86E1-82316FAE5F65Q35185514-C97C0F2E-A7EB-4A6A-B2E4-E62F4C1D493FQ36301067-9A578F0D-41EF-4858-9C14-1F28D205489EQ37330760-CB1765A6-E9B0-463A-92E7-C5C639D3C9ADQ40546885-8117A7A3-9780-4130-B31B-CBA7BBBDA5D1Q41061564-3B7377FD-DD07-4986-AE2C-A9D1248DF656Q41722010-E35A47C6-99B4-4705-9B01-90724FC2CDA1Q41986955-0E96A9DB-C417-45A5-843E-B0B9CF4E96A1Q42412184-C7638A56-B80A-4792-A1E3-C68EF66DDD70Q44350044-5D7DB8EF-ED39-4ABF-827F-1F3CA065238CQ57095558-36D27F6C-906C-4C44-B77B-7CC33AAAD1DB
P2860
In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vitro and in vivo pharmacol ...... ensity to alter motor function
@ast
In vitro and in vivo pharmacol ...... ensity to alter motor function
@en
In vitro and in vivo pharmacol ...... ensity to alter motor function
@nl
type
label
In vitro and in vivo pharmacol ...... ensity to alter motor function
@ast
In vitro and in vivo pharmacol ...... ensity to alter motor function
@en
In vitro and in vivo pharmacol ...... ensity to alter motor function
@nl
prefLabel
In vitro and in vivo pharmacol ...... ensity to alter motor function
@ast
In vitro and in vivo pharmacol ...... ensity to alter motor function
@en
In vitro and in vivo pharmacol ...... ensity to alter motor function
@nl
P2093
P2860
P1476
In vitro and in vivo pharmacol ...... ensity to alter motor function
@en
P2093
Catalina R Bohotin
Kurt Stübegger
Muhammad F Asim
P2860
P304
P356
10.1016/J.EJPS.2010.05.018
P407
P577
2010-06-18T00:00:00Z